FDA and CDC Considering , 'Approval' of a Fourth COVID Shot , for People Over 50.<br />Poynter reports that United States citizens <br />over 50 could be approved to receive a fourth <br />dose of COVID vaccination as early as this week. .<br />The Food and Drug Administration and Centers for Disease <br />Control and Prevention are reportedly considering<br />a “permissive recommendation” for a fourth dose. .<br />The move would fall short of a full recommendation, instead just allowing people who wish to <br />receive an additional booster to get one. .<br />Granting a “permissive recommendation” allows <br />the FDA to skip the special review panels <br />required to grant the fourth dose full approval. .<br />Granting a “permissive recommendation” allows <br />the FDA to skip the special review panels <br />required to grant the fourth dose full approval. .<br />According to Poynter, the review panel that <br />determines the efficacy and safety of drugs <br />is not scheduled to meet until April. .<br />According to Poynter, the review panel that <br />determines the efficacy and safety of drugs <br />is not scheduled to meet until April. .<br />At that time, the panel will take up <br />the topic of who should be eligible <br />for a fourth dose in 2022. .<br />According to Poynter, one of the main issues<br />regarding boosters is a matter of timing. .<br />Anyone receiving a booster now runs the risk <br />of protection fading by the time a possible <br />fall/winter resurgence of COVID rolls around. .<br />Poynter reports that health experts consider <br />a surge in the fall of 2022 to be "highly likely.".<br />Currently, drug companies are working to create <br />vaccine formulas that would be effective against <br />different variants of the coronavirus.
